Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Johnson

Showing results (341-350 of 392) with videos related to

Pageof 40
Sort By:
JAMA Neurology|April 3, 2023
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission TomographyGillian T Coughlan, Tobey J Betthauser, Rory Boyle, et al.
Science Translational Medicine|January 21, 2021
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomographyJustin S Sanchez, J Alex Becker, Heidi I L Jacobs, et al.
Annals of Neurology|December 15, 2018
The impact of amyloid-beta and tau on prospective cognitive decline in older individualsReisa A Sperling, Elizabeth C Mormino, Aaron P Schultz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2025
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairmentsJessie Fanglu Fu, Arun Garimella, Alex Lapointe, et al.
Alzheimer'S Research & Therapy|October 30, 2020
Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuumMark A Dubbelman, Roos J Jutten, Sarah E Tomaszewski Farias, et al.
Annals of Neurology|October 6, 2017
<sup>18</sup> F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R Schonhaut, Corey T McMillan, Salvatore Spina, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsColin Birkenbihl, Hannah M Klinger, Michael J Properzi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2026
Whole blood gene expression moderates associations between AD biomarkers and cognitive decline in cognitively unimpaired older adultsHannah M Klinger, Mabel Seto, Vaibhav A Janve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumColin Birkenbihl, Hannah M Klinger, Michael J Properzi, et al.
Acta Neuropathologica|July 15, 2022
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementiaDiego Sepulveda-Falla, Justin S Sanchez, Maria Camila Almeida, et al.
Pageof 40

Showing results (341-350 of 392) with videos related to

Sort By:
Pageof 40
JAMA Neurology|April 3, 2023
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission TomographyGillian T Coughlan, Tobey J Betthauser, Rory Boyle, et al.
Science Translational Medicine|January 21, 2021
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomographyJustin S Sanchez, J Alex Becker, Heidi I L Jacobs, et al.
Annals of Neurology|December 15, 2018
The impact of amyloid-beta and tau on prospective cognitive decline in older individualsReisa A Sperling, Elizabeth C Mormino, Aaron P Schultz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2025
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairmentsJessie Fanglu Fu, Arun Garimella, Alex Lapointe, et al.
Alzheimer'S Research & Therapy|October 30, 2020
Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuumMark A Dubbelman, Roos J Jutten, Sarah E Tomaszewski Farias, et al.
Annals of Neurology|October 6, 2017
<sup>18</sup> F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R Schonhaut, Corey T McMillan, Salvatore Spina, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsColin Birkenbihl, Hannah M Klinger, Michael J Properzi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2026
Whole blood gene expression moderates associations between AD biomarkers and cognitive decline in cognitively unimpaired older adultsHannah M Klinger, Mabel Seto, Vaibhav A Janve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumColin Birkenbihl, Hannah M Klinger, Michael J Properzi, et al.
Acta Neuropathologica|July 15, 2022
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementiaDiego Sepulveda-Falla, Justin S Sanchez, Maria Camila Almeida, et al.
Pageof 40